• Home

• About us

• Product Development
  
  • Research & Technology
  • Products
    • Intensive Care Units
    • Patient Management
    • Future Products
  • Clinical Development
  • Quality Management
  • IP Portfolio
  
  
  

• Investors / Media

• Diabetes Resources

• Careers

Intensive Care Units

Intensive Care Units Studies of Greet Van den Berghe et al.* have shown that tight glucose control has a positive outcome with regard to morbidity and mortality of diabetic and non-diabetic patients in intensive care units (ICU).

Continuous monitoring of glucose levels is essential for optimal insulin therapy in the ICU to achieve a target glycaemia between 80 to 110 mg/dl (4.4 to 6.1 mmol/l). Glucose sensors for intensive care units must measure blood glucose levels with a high degree of accuracy, especially in the low ranges (below 70 mg/dl or 3.8 mmol/l).

Basic requirements are a short response time and immediate information.

* Greet Van den Berghe et al, Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients, Crit Care Med 2006, Volume 34, No. 3.


Sensile Medical’s Glucose Sensor for Intensive Care Units

Sensile Medical is developing a glucose sensor especially designed to fulfil the needs of the ICU, that will provide accurate measurements in low and high glucose levels, require minimal calibration interventions, and will be cost-effective.




"Sensile Medical`s glucose sensor helps to signal glycemic excursions and to optimize intensive insulin therapy of patients in intensive care units."